Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00270933 · ClinicalTrials.gov registry record
MAVRIC VR ICD Registry
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 742
- Enrollment target
NCT00270933: Completed study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT00270933 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 742 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00270933 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 742 participants
- Enrollment target
Study Summary
The purpose of this registry is to collect information on the health status of patients receiving Marquis/Maximo VR Implantable Cardiac Defibrillators (ICDs), how the devices are being programmed and how this correlates to clinical patient outcome.
Interventions
- DEVICE Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 742 participants |
| Start Date | 2004-01 |
| Est. Completion | 2005-12 |
What the finished NCT00270933 record still lists
NCT00270933 is an observational study that tracks outcomes without assigning an intervention. The registered 742 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Registry is the first listed.
NCT00270933 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00270933 about?
NCT00270933 is a clinical study titled "MAVRIC VR ICD Registry". The purpose of this registry is to collect information on the health status of patients receiving Marquis/Maximo VR Implantable Cardiac Defibrillators (ICDs), how the devices are being programmed and how this correlates to clinical patient outcome.
What is the current status of trial NCT00270933?
This trial is currently completed. The enrollment target is 742 participants. The study started on 2004-01. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00270933?
The interventions under investigation include: Registry (DEVICE).
Who is sponsoring clinical trial NCT00270933?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05786417 · 741 participants · Phase 4
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
- NCT06556563 · 741 participants · Phase 3
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
- NCT05619185 · 744 participants · NA
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
- NCT06417814 · 744 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia